Q: Well Health certainly has made a move and great to see. Is it too much or just finally being valued for its potential.
Thanks John
Thanks John
5i Research Answer:
Put another way, WELL is just back to where it was in November 2021. Investors just didn't like it for a while, even though EPS went from a loss of 3c in 2020 to an estimated profit of 30c next year. At about 21X forward earnings, we would not see it as particularly expensive. It did close an acquisition this week, and momentum/volume are picking up. We would see the move as long overdue and would not see it as 'too much'.